BatchLine, who provides digital solutions of groundbreaking cloud EBR that simplify and streamline operations is thrilled to announce that Cyto-Facto, a leading provider in the field of cell and gene therapy is not only our highly valued customer but also our official partnership.
This collaboration marks a significant milestone in advancing the health and well-being of patients who need cutting-edge cell and gene therapies.
This collaboration marks a significant milestone in advancing the health and well-being of patients who need cutting-edge cell and gene therapies.
(Left) Dave Margetts, CEO at BatchLine
(Right) Shin Kawamata, CEO at Cyto Facto
(Right) Shin Kawamata, CEO at Cyto Facto
Further information, please contact us or email directly to info@batchline.com
(Left) David Holt, Managing Director at BatchLine
(Right) Dave Margetts, CEO at BatchLine
(Right) Dave Margetts, CEO at BatchLine
